all of medicine that has put itself in battle order in an attempt to provide an answer to the spread of SARS-CoV-2. The Institut Curie, whose research focuses on the fight against cancer, launched several projects during the first wave of contamination. The results of this work will allow us to better tackle possible future waves. ” data-reactid=”23″>The Covid-19 crisis revealed the importance of scientific research. If epidemiologists and virologists have been at the heart of research, it is all of medicine that has put itself in battle order in an attempt to provide an answer to the spread of SARS-CoV-2. The Institut Curie, whose research focuses on the fight against cancer, launched several projects during the first wave of contamination. The results of this work will allow us to better tackle possible future waves.
world, his team is working on developing a vaccine. But it would not be directed specifically against the Covid-19. It would serve as the basis for several diseases. “Our vaccine is a biological vaccine, comprising a small inert virus combined with a molecule of the virus against which we want to vaccinate. The virus and the adjuvant are in the same particle. It is a strength, because once injected, the product will reach the cells with the protein against which it is necessary to vaccinate and the adjuvant which will multiply the effects. This promotes its effectiveness.“ Studies have shown that this vaccine is effective against several viruses, as well as against cancer. The objective of the research project is now to test this new combination on the Covid-19. “We have succeeded in showing that a vaccine developed with the protein “Spike”, this protein of the virus which allows it to bind to cellular receptors of the organism, works in vitro, therefore on a cell. It activates the immunomodulatory pathway“This means that a vaccine, made up of this virus protein, could activate the immune response. […]” data-reactid=”25″>“There are no specific antivirals against the coronavirus family and therefore not on Covid-19 either.“, Explain Nicolas Manel, director of research at Inserm, head of the Immunity and Cancer team at the Institut Curie. Like many researchers around the world, his team is working on developing a vaccine. But it would not be directed specifically against the Covid-19. It would serve as the basis for several diseases. “Our vaccine is a biological vaccine, comprising a small inert virus combined with a molecule of the virus against which we want to vaccinate. The virus and the adjuvant are in the same particle. It is a strength, because once injected, the product will reach the cells with the protein against which it is necessary to vaccinate and the adjuvant which will multiply the effects. This promotes its effectiveness.“ Studies have shown that this vaccine is effective against several viruses, as well as against cancer. The objective of the research project is now to test this new combination on the Covid-19. “We have succeeded in showing that a vaccine developed with the protein “Spike”, this protein of the virus which allows it to bind to cellular receptors of the organism, works in vitro, therefore on a cell. It activates the immunomodulatory pathway“This means that a vaccine, made up of this virus protein, could activate the immune response. […]
Read more on sciencesetavenir.fr
Read also
–
